Media coverage about Innophos Holdings (NASDAQ:IPHS) has been trending somewhat positive this week, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Innophos Holdings earned a media sentiment score of 0.09 on Accern’s scale. Accern also gave headlines about the specialty chemicals company an impact score of 46.873434370604 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.
Shares of Innophos Holdings (IPHS) traded down 2.30% during mid-day trading on Monday, reaching $48.10. The company’s stock had a trading volume of 17,902 shares. The stock has a market capitalization of $932.95 million, a P/E ratio of 21.00 and a beta of 0.88. The company’s 50-day moving average price is $48.35 and its 200-day moving average price is $45.47. Innophos Holdings has a 12-month low of $41.66 and a 12-month high of $58.22.
Innophos Holdings (NASDAQ:IPHS) last released its quarterly earnings data on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. Innophos Holdings had a return on equity of 13.79% and a net margin of 6.46%. The business had revenue of $179.14 million for the quarter, compared to the consensus estimate of $172.65 million. During the same quarter in the previous year, the company posted $0.63 EPS. The company’s revenue was down 1.5% compared to the same quarter last year. On average, equities research analysts forecast that Innophos Holdings will post $2.51 earnings per share for the current fiscal year.
IPHS has been the subject of several research reports. Zacks Investment Research raised Innophos Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. BidaskClub lowered Innophos Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, July 12th.
COPYRIGHT VIOLATION WARNING: “Innophos Holdings (IPHS) Receiving Somewhat Favorable Media Coverage, Report Finds” was originally published by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/10/30/innophos-holdings-iphs-receiving-somewhat-favorable-media-coverage-report-finds.html.
About Innophos Holdings
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
What are top analysts saying about Innophos Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innophos Holdings Inc. and related companies.